SCHEMBL2486478

SCHEMBL2486478

COc1ccc(CN2CCc3c(cnc4[nH]ncc34)C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 1/20 0.48
DHFR P00374 1/20 0.48
ABCB1 P08183 2/20 0.47
ABCC1 P33527 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
BRS3 P32247 1/20 0.45
DRD2 P14416 3/20 0.44
DRD4 P21917 3/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
ROCK2 O75116 2/20 0.43
CCR2 P41597 1/20 0.43
ROCK1 Q13464 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
TNF P01375 1/20 0.43
NOD2 Q9HC29 1/20 0.43
NOD1 Q9Y239 1/20 0.43
CLPP Q16740 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803011 0.86 FAAH (0.45) MAP3K11ALDH1A1POLBACHE
SCHEMBL31750384 0.81 ABCB1 (0.50) DHFRABCB1ABCC1ABCG2BRS3
SCHEMBL2489846 0.80 ABCB1 (0.47) DHFRABCB1ABCC1ABCG2DRD2
SCHEMBL2802910 0.77 PKM (0.52) ALDH1A1
SCHEMBL31749747 0.75 ABCB1 (0.53) DHFRABCB1ABCC1ABCG2BRS3
SCHEMBL2806833 0.71 KMT2A (0.49) ALDH1A1
SCHEMBL2808052 0.70 PKM (0.47) ALDH1A1ROCK2ROCK1
SCHEMBL31750019 0.70 ABCB1 (0.50) DHFRABCB1ABCC1ABCG2BRS3
SCHEMBL12315714 0.70 ALDH1A1 (0.48) ALDH1A1POLBSIGMAR1
SCHEMBL13302252 0.69 TNF (0.70) ABCB1ABCC1ABCG2DRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
EP-2379551-A1 SUBSTITUTED PYRAZOLO [3, 4-B]PYRIDINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 MAP3K11 1293/4885DHFR 20/4885ABCB1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.